Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
C2N Diagnostics
MedTech
Samsung backs Alzheimer's blood test developer C2N Diagnostics
Samsung backed the Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial work and R&D pipeline.
Conor Hale
Mar 13, 2025 12:15pm
Eisai backs C2N's Alzheimer's blood tests with up to $15M
Mar 6, 2024 2:54pm
Alzheimer's blood test matches spinal fluid accuracy in study
Feb 23, 2024 10:40am
C2N Diagnostics launches revamped Alzheimer's blood test
Aug 23, 2023 10:36am
C2N blood test outperforms other Alzheimer's tests in 2 studies
Apr 10, 2023 12:16pm
C2N launches tau-tallying blood test for Alzheimer's research
May 18, 2022 3:49pm
